Virbac’s Q3 sales were impacted by tough comps in the companion animals (CA) segment and an adverse regulatory event in the food producing animals segment. While geopolitical uncertainties and rising inflation are near-term risks, which probably also influenced the moderation in the 2022 guidance, the underlying potential of the focus markets remains intact. And despite the firm’s smaller scale vis-à-vis competitors, a net cash position implies that there’s ample room to withstand operational ch ....
